• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. Little data exists about how to get adhd meds without diagnosis long-term exposure to these medications could affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against potential risks to the foetus. Physicians don't have the data to give clear advice but they can provide information about risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy were not at a higher risk of fetal malformations or structural birth defects. Researchers used a large population-based case control study to compare the incidence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to ensure that the classification was accurate and to eliminate any bias.

The research conducted by the researchers had some limitations. The researchers were not able, in the first place to distinguish the effects of the medication from the disorder. This limitation makes it difficult for researchers to determine if the small differences observed between the groups that were exposed to the use of medication, or if they were caused by comorbidities. In addition, the researchers did not study long-term offspring outcomes.

The study did find that infants whose mothers took ADHD medication during pregnancy were at a greater risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or taken off their medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk for admission was not found to be influenced by the stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefits to both the mother and child of continued treatment for the woman's condition. Doctors should discuss with their patients about this and, if possible, help them improve coping skills which may reduce the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

Many doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are taken in the absence of clear and authoritative evidence regardless, so doctors must weigh what they know, the experiences of other doctors, and what research suggests on the subject as well as their own best medication for ocd and adhd judgment for each individual patient.

The issue of risk for infants can be difficult to determine. The research on this issue is based on observation instead of controlled studies and many of the findings are contradictory. Most studies limit their analysis to live births, which can underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study presented in the journal club addresses these limitations, by examining both information on deceased and live births.

The conclusion The conclusion: While some studies have found an association between ADHD medications and the risk of certain birth defects, other studies have found no connection and the majority of studies have a neutral or slight negative effect. In each case an in-depth analysis of the risks and benefits is required.

It can be challenging, if not impossible, for women with ADHD to stop taking their medication. In a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of isolation and family conflict for patients with ADHD. Additionally, the loss of medication can interfere with the ability to perform job-related tasks and drive safely, which are important aspects of daily life for many people with ADHD.

She recommends women who are uncertain about whether or not to stop medication in light of their pregnancy should consider informing family members, friends, and coworkers on the condition, its effects on daily functioning, and the advantages of continuing the current treatment regimen. It will also help a woman feel confident about her decision. Some medications can pass through the placenta. If the patient decides not to take her ADHD medication while breastfeeding, it is important to be aware that the drug could be passed on to her infant.

Birth Defects and Risk of

As the use and use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so does concern about the possible effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Researchers utilized two massive datasets to analyze over 4.3 million pregnancy and determine if the use of stimulant medications caused birth defects. Although the risk overall remains low, the researchers did find that first-trimester exposure to ADHD medicines was associated with a slightly higher rate of certain heart defects, such as ventriculo-septal defect (VSD).

The authors of the study did not find any association between early use of medication and congenital anomalies like facial deformities, or club feet. The results are in agreement with previous studies that have shown a small, but significant increase in cardiac malformations for women who began taking ADHD medication prior to the birth of their child. This risk increased during the latter part of pregnancy, when a lot of women began to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean delivery or have a low Apgar after birth and have a baby that needed help breathing when they were born. However the researchers of the study were not able to eliminate bias due to selection by limiting the study to women who did not have any other medical issues that could have contributed to the findings.

The researchers hope that their research will serve to inform the clinical decisions of physicians who see pregnant women. They recommend that, while a discussion of the benefits and risks is important, the decision to stop or keep treatment should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors also caution that, while stopping the medication is an option, it is not an option to consider due to the high incidence of depression and other mental health problems for women who are expecting or who are recently post-partum. Research has also shown that women who stop taking their medications will have a harder time adjusting to a life without them once the baby is born.

Nursing

It can be overwhelming becoming a mother. Women with ADHD can face severe challenges when they must deal with their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to a new routine. Many women decide to continue taking their ADHD medication during pregnancy.

The risk to a breastfeeding infant is not too high since the majority of stimulant medications is absorbed through breast milk at a low level. However, the rate of exposure to medications by the infant can differ based on dosage, how often it is administered, and the time of day it is administered. Additionally, different medications used to treat adhd enter the body of the baby differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn is not well understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the lack of research. This is a complicated decision for the patient, who must weigh the benefits of keeping her medication against the possible dangers to the fetus. In the meantime, until more information is available, GPs may ask pregnant patients whether they have any background of ADHD or if they plan to take medication in the perinatal period.

Many studies have shown that women can continue taking their ADHD medication safely during pregnancy and breast-feeding. In response, an increasing number of patients are choosing to do so. They have discovered, in consultation with their physicians, that the benefits of keeping their current medication outweigh any risk.

Women with ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should review their medications with their physician and discuss the advantages and disadvantages of continuing treatment, including Non Stimulant Adhd Medications For Adults-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD recognize their symptoms and the underlying disorder Learn about the available treatments and to reinforce existing coping strategies. This should be a multidisciplinary effort together with obstetricians, GPs, and psychiatrists. Pregnancy counselling should include the discussion of a treatment plan for both the mother as well as the child, monitoring for signs of deterioration, and the need for adjustments to the medication regimen.